arrow
U

Ulrich P. Jorde

montefiore medical center
H指数:67
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real World Adoption and Associated Outcomes of Aspirin Avoidance After HeartMate 3 Implantation: The PRAISE HM3 Study

Real World Adoption and Associated Outcomes of Aspirin Avoidance After HeartMate 3 Implantation: The PRAISE HM3 Study 心室辅助装置植入后阿司匹林避免使用的真实世界采用及关联结果:PRAISE HM3 研究

2026-10-120
OAAI
Survival Outcomes in Middle-aged and Older Patients with Advanced Heart Failure: A Propensity-Matched Analysis of HeartMate 3 LVAD and Heart Transplant Using MOMENTUM 3 and UNOS Registry

中老年晚期心力衰竭患者生存结局:基于MOMENTUM 3和UNOS登记研究的HeartMate 3左心室辅助装置与心脏移植的倾向性匹配分析

2026-05-100
OAAI
Early Right Ventricular Failure Following HeartMate 3 Left Ventricular Assist Device Implantation: Risk Factors and Outcomes

HeartMate 3左心室辅助装置植入术后早期右心室衰竭:危险因素与结局

2026-03-260
PRE
Impact of Atrial Fibrillation, Diabetes Mellitus and Obesity on Outcomes with Aspirin Avoidance and Hemocompatibility with a Left Ventricular Assist Device: An analysis from the ARIES-HM3 Trial

心房颤动、糖尿病和肥胖对停用阿司匹林及左心室辅助装置血液相容性影响的结果:一项来自ARIES-HM3试验的分析

2025-11-260
OAAI
Natural History of Atrial versus Ventricular Secondary Tricuspid Regurgitation: Insights From The Bronx-Valve Registry

房间隔与室间隔继发性三尖瓣反流的自然史:来自Bronx-Valve登记研究的见解

2025-11-010
PRE
Withdrawal of aspirin in patients with left ventricular assist device treated with vitamin K antagonists: impact of anticoagulation quality in the randomized ARIES-HM3 trial

左心室辅助装置且接受维生素K拮抗剂治疗的患者停用阿司匹林:随机ARIES-HM3试验中抗凝质量的影响

2025-11-011
OA
Angiotensin–Neprilysin Inhibition and Left Ventricular Assist Device Therapy –Primary results of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 LVAD recipients (ENVAD-HF)

血管紧张素-中性肽链内切酶抑制与左心室辅助装置疗法——多中心、随机、开放标签、平行组研究评估沙库巴曲/缬沙坦在HeartMate 3 LVAD受者中应用的主要结果(ENVAD-HF)

2025-08-310
OAAI
Rationale, design and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 LVAD recipients (ENVAD-HF)

研究背景、设计与基线特征:一项多中心、随机、开放标签、平行分组研究,旨在评估沙库巴曲/缬沙坦在HeartMate 3 LVAD受者中的使用(ENVAD-HF研究)。

2025-08-140
PREAI
Does Switching From Trimethoprim/Sulfamethoxazole to Atovaquone Result in Less Hyperkalemia? A Single-Center Retrospective Analysis in Heart Transplant Patients

从甲氧苄啶/磺胺甲噁唑转换为阿托伐醌是否会导致高钾血症减少?——一项在心脏移植患者中的单中心回顾性分析

2025-05-120
PRE
Sodium-Glucose Cotransporter 2 Inhibitors in Tafamidis-Treated Transthyretin Amyloid Cardiomyopathy: A Contemporary Real-World Analysis

Sodium-Glucose Cotransporter 2抑制剂在Tafamidis治疗下的甲状腺素转运蛋白淀粉样变性心肌病:一项当代真实世界分析

2025-05-010
PRE